1-4 of 4
D. Li
Close
Sort by
Journal Articles

Differential Expression of TCF3 Target Genes Defines Subclasses of Diffuse Large B-Cell Lymphoma with Striking Differences in Clinical Outcome Following R-CHOP Therapy

Kathrin Tyryshkin, PhD, Yi D Li, MD, David Good, MD, Lois E. Shepherd, MD, Tara Baetz, MD FRCPC, Michael J. Rauh, MD PhD, David P. LeBrun, MD
Journal: Blood
Blood (2016) 128 (22): 3037.
https://doi.org/10.1182/blood.V128.22.3037.3037
Published: 2016
Journal Articles

The Preparative Method and Clinical Application of Autologous memory T Lymphocyte.

D. LI, MD, PhD, Jian Ouyang, Sr, CP LI, Dr, Jh Chen, PhD, M. Zhou, MD, Rong-Fu Zhou, Sr
Journal: Blood
Blood (2009) 114 (22): 5123.
https://doi.org/10.1182/blood.V114.22.5123.5123
Published: 2009
Journal Articles

A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Phase II Study of Oral Fludarabine in Untreated B-Cell Chronic Lymphocytic Leukemia.

C. Shustik, R. Turner, P. Desjardins, L. Fernandez, S. Rubin, L. Larratt, A. Duncan, D. Rizi, A. Sadura, L. Shepherd, D. Li, L. Rassenti, T. Kipps
Journal: Blood
Blood (2005) 106 (11): 2977.
https://doi.org/10.1182/blood.V106.11.2977.2977
Published: 2005
Journal Articles

Detection of Microdeletions and Amplifications in Primary Human Acute Myeloid Leukemia (AML) Genomes Using Ultradense Oligomer Tiling Path Arrays and Comparative Genomic Hybridization (CGH).

Matthew J. Walter, MD, R. R. Ries, BS, X. D. Li, W. J. Shannon, PhD, J. Payton, MD, PhD, C. D. Bloomfield, MD, K. Mrozek, MD, A. S. Ruppert, J. DiPersio, MD, PhD, D. Link, MD, M. Tomasson, MD, T. Graubert, MD, H. McLeod, PharmD, S. Devine, MD, M. Watson, MD, PhD, S. Heath, J. Baty, BA, K. Trinkaus, PhD, J. Armstrong, E. Mardis, PhD, R. Wilson, PhD, R. Selzer, PhD, T. Richmond, PhD, P. Eis, PhD, T. J. Ley, MD
Journal: Blood
Blood (2005) 106 (11): 2350.
https://doi.org/10.1182/blood.V106.11.2350.2350
Published: 2005